We are no longer offering CME for this course. Please feel free to take the course for free! Start here.
CME Credit Information
Course Title: Reducing the Risk of Perioperative Death (BBAC)
Course Number: #MED08002
Period of Certification: May 23, 2005 - June 30, 2008
Designation: 2 AMA PRA Category 1 Credits
CME Credit Cost: $35.00 U.S. (payable by credit card upon
completion of the course, final quiz and course evaluation, from
UCSF's secure CME website.)
Accreditation Statement
The University of California, San Francisco School of Medicine (UCSF)
is accredited by the Accreditation Council for Continuing Medical
Education to provide continuing medical education for Physicians.
Credit Designation Statement
UCSF designates this educational activity for a maximum of 2 AMA
PRA category 1 credits. Each physician should claim only those credits
that he/she
actually spent in the activity.
Intended Audience
The intended audience consists of anesthesiologists, certified nurse
anesthetists, surgeons, cardiologists, intensivists and internists.
Principal Faculty and Credentials
Arthur Wallace, M.D., Ph.D.
Professor of Anesthesiology and Perioperative Medicine,
UCSF Medical Center
Attending Anesthesiologist, San Francisco VA Medical Center
Media used - Web-based educational materials
Method of physician participation in the learning
process
Reading and/or listening to the web presentation. Online registration,
quizzes and evaluation forms. Online discussion forum and email
contact with principal faculty will also be available.
Estimated time to complete the course - 2
hours
Disclosure: Dr. Wallace has disclosed ownership interest
in Cardiac Engineering. All conflicts of interest have been resolved
in accordance with the ACCME's Standards for Commercial Support.
Date of original release - April 3, 2005,
Most recent update - June 29, 2005
Termination date - June 30, 2008 |
Course Objectives:
Beta Blockers: Non-Cardiac Surgery for
Patients with Cardiac Disease
1. Participants can describe the epidemiology of
cardiac disease and patients coming for cardiac and non-cardiac
surgery in the United States.
2. Participants can identify the risk factors for cardiac morbidity
and mortality.
3. Participant can identify strategies for cardiac risk stratificationand
describe the relative merits of each approach.
4. Participants can describe the relative merits of different
strategies for cardiac risk reduction including preoperative risk
stratification, pre-operative PCI, pre-operative CABG and discuss
risks and benefits of each.
5. Participants can explain the risks and benefits of CABG surgery
including death, MI, neurologic, and neurocognitive changes.
6. Participants can explain the risks of platelet inhibitors with
and without intra-coronary stents and identify a plan of action
for elective and emergency surgery for a patient with a drug eluting
and non-drug eluting intracoronary stent.
7. Participants can describe different pharmacologic therapies
for cardiac risk reduction including beta blockers, clonidine,
and newer agents. Participant can describe the number needed to
treat and cost to treat for each technique for cardiac risk reduction.
8. Participant can explain how to implement a program for cardiac
risk reduction therapy.
|
